Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells

This publication has 35 references indexed in Scilit:

• Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease
  Synapse, 1999
• Neurotransmitter transporters as molecular targets for addictive drugs
  Drug and Alcohol Dependence, 1998
• Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type
  Brain Research, 1994
• SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain
  Journal of Neural Transmission, 1993
• High‐affinity binding of [¹²⁵I]RTI‐55 to dopamine and serotonin transporters in rat brain
  Synapse, 1992
• [125I]RTI-55: a potent ligand for dopamine transporters
  European Journal of Pharmacology, 1991
• Autoradiographic localization of cocaine binding sites by [³H]CFT ([³H]WIN 35,428) in the monkey brain
  Synapse, 1990
• Biochemical and Pharmacological Characterization of [³H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex
  Journal of Neurochemistry, 1987
• High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system
  European Journal of Pharmacology, 1986
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973